These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 36655832)

  • 1. Pediatric Minimal Change Disease and AKI following the Pfizer-BioNTech COVID-19 Vaccine: causal or incidental correlation?
    Annicchiarico Petruzzelli L; Minale B; Serio V; De Luca A; Marino Marsilia G; Campione S; Diomedi Camassei F; D'Arcangelo R; Luongo I; Lepore L; Giannattasio P; Molino D; Pirro L; Lonardo MC; Malgieri G; Pecoraro C
    G Ital Nefrol; 2022 Dec; 39(6):. PubMed ID: 36655832
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Minimal Change Disease Following the Pfizer-BioNTech COVID-19 Vaccine.
    Lebedev L; Sapojnikov M; Wechsler A; Varadi-Levi R; Zamir D; Tobar A; Levin-Iaina N; Fytlovich S; Yagil Y
    Am J Kidney Dis; 2021 Jul; 78(1):142-145. PubMed ID: 33839200
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Minimal Change Disease With Severe Acute Kidney Injury Following the Oxford-AstraZeneca COVID-19 Vaccine: A Case Report.
    Leclerc S; Royal V; Lamarche C; Laurin LP
    Am J Kidney Dis; 2021 Oct; 78(4):607-610. PubMed ID: 34242687
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New-onset pediatric nephrotic syndrome following Pfizer-BioNTech SARS-CoV-2 vaccination: a case report and literature review.
    Nakazawa E; Uchimura T; Hirai Y; Togashi H; Oyama Y; Inaba A; Shiga K; Ito S
    CEN Case Rep; 2022 May; 11(2):242-246. PubMed ID: 34782983
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nephrotic syndrome with minimal change disease after the Pfizer-BioNTech COVID-19 vaccine: two cases.
    Hartley JL; Bailey N; Sharma A; Shawki H
    BMJ Case Rep; 2022 Mar; 15(3):. PubMed ID: 35246429
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Minimal change disease following the Moderna COVID-19 vaccine: first case report.
    Thappy S; Thalappil SR; Abbarh S; Al-Mashdali A; Akhtar M; Alkadi MM
    BMC Nephrol; 2021 Nov; 22(1):376. PubMed ID: 34763669
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New-onset Nephrotic Syndrome after Janssen COVID-19 Vaccination: a Case Report and Literature Review.
    Lim JH; Han MH; Kim YJ; Kim MS; Jung HY; Choi JY; Cho JH; Kim CD; Kim YL; Park SH
    J Korean Med Sci; 2021 Aug; 36(30):e218. PubMed ID: 34342187
    [TBL] [Abstract][Full Text] [Related]  

  • 8. De Novo Minimal Change Disease following Vaccination with the Pfizer/BioNTech SARS-CoV-2 Vaccine in a Living Kidney Donor.
    Marinaki S; Kolovou K; Liapis G; Skalioti C; Tsiakas S; Boletis I
    Medicina (Kaunas); 2021 Dec; 58(1):. PubMed ID: 35056345
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exacerbation of Minimal Change Disease Following mRNA COVID-19 Vaccination.
    Pirzadeh A; Emami S; Zuckerman JE; Nobakht N
    Am J Case Rep; 2023 Nov; 24():e941621. PubMed ID: 37941318
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Minimal change disease and acute kidney injury following the Pfizer-BioNTech COVID-19 vaccine.
    D'Agati VD; Kudose S; Bomback AS; Adamidis A; Tartini A
    Kidney Int; 2021 Aug; 100(2):461-463. PubMed ID: 34000278
    [No Abstract]   [Full Text] [Related]  

  • 11. Relapse of minimal change disease following the third mRNA COVID-19 vaccination: a case report and literature review.
    Teragaki M; Tanaka M; Yamamoto H; Watanabe T; Takeoka J; Fukumi A; Maeda K; Takami Y; Saita H; Iwanari S; Ikeda M; Takeoka H
    CEN Case Rep; 2024 Feb; 13(1):53-58. PubMed ID: 37244881
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Minimal change disease soon after Pfizer-BioNTech COVID-19 vaccination.
    Kobayashi S; Fugo K; Yamazaki K; Terawaki H
    Clin Kidney J; 2021 Dec; 14(12):2606-2607. PubMed ID: 34938534
    [TBL] [Abstract][Full Text] [Related]  

  • 13. De novo Minimal Change Disease in an Adolescent after Pfizer-BioNTech COVID-19 Vaccination: A Case Report.
    Pella E; Sarafidis PA; Alexandrou ME; Stangou M; Nikolaidou C; Kosmidis D; Papagianni A
    Case Rep Nephrol Dial; 2022; 12(1):44-49. PubMed ID: 35611026
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A child with crescentic glomerulonephritis following SARS-CoV-2 mRNA (Pfizer-BioNTech) vaccination.
    Kim S; Jung J; Cho H; Lee J; Go H; Lee JH
    Pediatr Nephrol; 2023 Jan; 38(1):299-302. PubMed ID: 35854121
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of hematological parameters and thrombocytopenia following Pfizer-BioNTech (BNT162b2) SARS-CoV-2 vaccination.
    Algaissi A; Alamer E; Jeraiby M; Alomaish A; Elrhima O; Qumayi S; Qasir NA; Areeshi H; Masmali A; Alhazmi A
    Saudi Med J; 2022 Jun; 43(6):567-571. PubMed ID: 35675927
    [TBL] [Abstract][Full Text] [Related]  

  • 16. COVID-19 vaccines: comparison of biological, pharmacological characteristics and adverse effects of Pfizer/BioNTech and Moderna Vaccines.
    Meo SA; Bukhari IA; Akram J; Meo AS; Klonoff DC
    Eur Rev Med Pharmacol Sci; 2021 Feb; 25(3):1663-1669. PubMed ID: 33629336
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IgA nephropathy relapse following COVID-19 vaccination treated with corticosteroid therapy: case report.
    Watanabe S; Zheng S; Rashidi A
    BMC Nephrol; 2022 Apr; 23(1):135. PubMed ID: 35392838
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Minimal Change Nephrotic Syndrome with Acute Kidney Injury after the Administration of Pfizer-BioNTech COVID-19 Vaccine.
    Gulumsek E; Ozturk DD; Ozturk HA; Saler T; Erdogan KE; Bashir AM; Sumbul HE
    Case Rep Infect Dis; 2023; 2023():5122228. PubMed ID: 36875495
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Minimal Change Disease After First Dose of Pfizer-BioNTech COVID-19 Vaccine: A Case Report and Review of Minimal Change Disease Related to COVID-19 Vaccine.
    Hanna J; Ingram A; Shao T
    Can J Kidney Health Dis; 2021; 8():20543581211058271. PubMed ID: 34804557
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Side effects of Pfizer/BioNTech (BNT162b2) COVID-19 vaccine reported by the Birzeit University community.
    Abukhalil AD; Shatat SS; Abushehadeh RR; Al-Shami N; Naseef HA; Rabba A
    BMC Infect Dis; 2023 Jan; 23(1):5. PubMed ID: 36604613
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.